| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 5, 2003
From Pharmacologie et Physico-Chimie des Interactions Cellulaires et Moléculaires, UMR CNRS 7034, Faculté de Pharmacie, Illkirch, France (S.M., A.T., R.A.); Institut d’Hématologie et d’Immunologie, ULP, Strasbourg, France; and Unité 143 INSERM, Hôpital de Bicêtre, France (B.H., M.C.M., O.M., J.-M.F.). * To whom correspondence should be addressed. E-mail: nain{at}pharma.u-strasbg.fr.
Background--Microparticles (MPs) are membrane vesicles with procoagulant and proinflammatory properties released during cell activation. The present study was designed to dissect the effects evoked by T lymphocyte-derived MPs on vascular function. Methods and Results--MPs were produced by treatment of the human lymphoid CEM T cell line with actinomycin D or phytohemagglutinin. Incubation of mouse aortic rings with 30 nmol/L MPs resulted in a time-dependent impairment of acetylcholine-induced relaxation of precontracted vessels, with a maximal reduction after 24 hours. MPs also impaired shear stress-induced dilatation of mouse small mesenteric arteries by affecting the nitric oxide (NO) and prostacyclin but not the endothelium-derived hyperpolarizing factor components of the response. However, neither alteration of calcium signaling in response to agonists nor reduction of cyclooxygenase-1 expression accounted for the impairment of the NO and prostacyclin components of the endothelial response. The effect of MPs was rather because of a decrease in expression of endothelial NO synthase and an overexpression of caveolin-1. Furthermore, lymphocyte-derived MPs from diabetic patients or in vivo circulating MPs from either diabetic or HIV-infected patients reduced endothelial NO synthase expression. Finally, the effects of MPs on endothelial cells were not driven through CD11a/CD18 adhesion molecules or the Fas/FasL pathway. Conclusions--MPs from T cells induce endothelial dysfunction in both conductance and resistance arteries by alteration of NO and prostacyclin pathways. MPs regulate protein expression for endothelial NO synthase and caveolin-1. These data contribute to a better understanding of the deleterious effects of enhanced circulating MPs observed in disorders with cardiovascular or immune complications.
Revised on November 27, 2003
Accepted on December 10, 2003
Shed Membrane Particles From T Lymphocytes Impair Endothelial Function and Regulate Endothelial Protein Expression
Sophie Martin PhD,
This article has been cited by other articles:
![]() |
O. Morel, F. Toti, N. Morel, and J.-M. Freyssinet Microparticles in endothelial cell and vascular homeostasis: are they really noxious? Haematologica, March 1, 2009; 94(3): 313 - 317. [Full Text] [PDF] |
||||
![]() |
H. A. Mostefai, F. Meziani, M. L. Mastronardi, A. Agouni, C. Heymes, C. Sargentini, P. Asfar, M. C. Martinez, and R. Andriantsitohaina Circulating Microparticles from Patients with Septic Shock Exert Protective Role in Vascular Function Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1148 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Daniel, L. Dou, Y. Berland, P. Lesavre, L. Mecarelli-Halbwachs, and F. Dignat-George Circulating microparticles in renal diseases Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2129 - 2132. [Full Text] [PDF] |
||||
![]() |
H. A. Mostefai, A. Agouni, N. Carusio, M. L. Mastronardi, C. Heymes, D. Henrion, R. Andriantsitohaina, and M. C. Martinez Phosphatidylinositol 3-Kinase and Xanthine Oxidase Regulate Nitric Oxide and Reactive Oxygen Species Productions by Apoptotic Lymphocyte Microparticles in Endothelial Cells J. Immunol., April 1, 2008; 180(7): 5028 - 5035. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bakouboula, O. Morel, A. Faure, F. Zobairi, L. Jesel, A. Trinh, M. Zupan, M. Canuet, L. Grunebaum, A. Brunette, et al. Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 536 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tesse, G. Al-Massarani, R. Wangensteen, S. Reitenbach, M. C. Martinez, and R. Andriantsitohaina Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-{gamma} Agonist, Prevents Microparticle-Induced Vascular Hyporeactivity through the Regulation of Proinflammatory Proteins J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 539 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yang, B. R. Mwaikambo, T. Zhu, C. Gagnon, J. Lafleur, S. Seshadri, P. Lachapelle, J.-C. Lavoie, S. Chemtob, and P. Hardy Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R467 - R476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Agouni, H. A. Mostefai, C. Porro, N. Carusio, J. Favre, V. Richard, D. Henrion, M. C. Martinez, and R. Andriantsitohaina Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release FASEB J, September 1, 2007; 21(11): 2735 - 2741. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-Jau, F. Dignat-George, and J.-M. Freyssinet Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation? Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2594 - 2604. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chironi, A. Simon, B. Hugel, M. Del Pino, J. Gariepy, J.-M. Freyssinet, and A. Tedgui Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2775 - 2780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Martinez, F. Larbret, F. Zobairi, J. Coulombe, N. Debili, W. Vainchenker, M. Ruat, and J.-M. Freyssinet Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens Blood, November 1, 2006; 108(9): 3012 - 3020. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Boulanger, N. Amabile, and A. Tedgui Circulating Microparticles: A Potential Prognostic Marker for Atherosclerotic Vascular Disease Hypertension, August 1, 2006; 48(2): 180 - 186. [Full Text] [PDF] |
||||
![]() |
N. Werner, S. Wassmann, P. Ahlers, S. Kosiol, and G. Nickenig Circulating CD31+/Annexin V+ Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 112 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Hsue and D. D. Waters What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection Circulation, December 20, 2005; 112(25): 3947 - 3957. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tesse, M. C. Martinez, B. Hugel, K. Chalupsky, C. D. Muller, F. Meziani, D. Mitolo-Chieppa, J.-M. Freyssinet, and R. Andriantsitohaina Upregulation of Proinflammatory Proteins Through NF-{kappa}B Pathway by Shed Membrane Microparticles Results in Vascular Hyporeactivity Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2522 - 2527. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Amabile, A. P. Guerin, A. Leroyer, Z. Mallat, C. Nguyen, J. Boddaert, G. M. London, A. Tedgui, and C. M. Boulanger Circulating Endothelial Microparticles Are Associated with Vascular Dysfunction in Patients with End-Stage Renal Failure J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3381 - 3388. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Boulanger and A. Tedgui Dying for attention: Microparticles and angiogenesis Cardiovasc Res, July 1, 2005; 67(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
M. C. Martinez, A. Tesse, F. Zobairi, and R. Andriantsitohaina Shed membrane microparticles from circulating and vascular cells in regulating vascular function Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1004 - H1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hugel, M. C. Martinez, C. Kunzelmann, and J.-M. Freyssinet Membrane Microparticles: Two Sides of the Coin Physiology, February 1, 2005; 20(1): 22 - 27. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |